SH2 domain binding to phosphopeptide ligands: potential for drug targeting
- PMID: 19273114
- DOI: 10.2741/3292
SH2 domain binding to phosphopeptide ligands: potential for drug targeting
Abstract
SH2 domains are modular components of a wide range of functionally diverse proteins involved in mammalian signal transduction including enzymes, adaptors, regulators and transcription factors. Members of the SH2 domain family recognize a wide variety of short tyrosine phosphorylated peptide motifs. Biochemical and structural studies have revealed key aspects of these interactions that account for their ability to discriminate between different sequence motifs. While the mechanism of phosphotyrosine (pTyr) recognition is remarkably conserved among the SH2 domains, differences in recognition of phosphopeptide residues N and especially C-terminal to the pTyr have been identified that contribute to selectivity. The basis for SH2- phosphopeptide recognition is discussed in light of the available structural and biochemical data with a focus on recent information regarding SH2 domains within a new class found within the signal transducer and activator of transcription (STAT) protein family.
Similar articles
-
Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.J Mol Biol. 1999 Nov 5;293(4):971-85. doi: 10.1006/jmbi.1999.3190. J Mol Biol. 1999. PMID: 10543978
-
Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.Biochemistry. 2000 Aug 22;39(33):10072-81. doi: 10.1021/bi000891n. Biochemistry. 2000. PMID: 10955995
-
Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.J Mol Biol. 2002 Feb 15;316(2):291-304. doi: 10.1006/jmbi.2001.5362. J Mol Biol. 2002. PMID: 11851339
-
SH2 Domain Binding: Diverse FLVRs of Partnership.Front Endocrinol (Lausanne). 2020 Sep 18;11:575220. doi: 10.3389/fendo.2020.575220. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33042028 Free PMC article. Review.
-
Molecular recognition by SH2 domains.Adv Protein Chem. 2002;61:161-210. doi: 10.1016/s0065-3233(02)61005-8. Adv Protein Chem. 2002. PMID: 12461824 Review.
Cited by
-
DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3.Trans Am Clin Climatol Assoc. 2022;132:61-76. Trans Am Clin Climatol Assoc. 2022. PMID: 36196170 Free PMC article.
-
Loops govern SH2 domain specificity by controlling access to binding pockets.Sci Signal. 2010 May 4;3(120):ra34. doi: 10.1126/scisignal.2000796. Sci Signal. 2010. PMID: 20442417 Free PMC article.
-
STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.FASEB J. 2016 Jan;30(1):129-40. doi: 10.1096/fj.15-273953. Epub 2015 Aug 31. FASEB J. 2016. PMID: 26324850 Free PMC article.
-
Generating and validating renewable affimer protein binding reagents targeting SH2 domains.Sci Rep. 2024 Nov 16;14(1):28322. doi: 10.1038/s41598-024-79357-4. Sci Rep. 2024. PMID: 39550397 Free PMC article.
-
Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin.EMBO J. 2012 Mar 7;31(5):1308-19. doi: 10.1038/emboj.2011.496. Epub 2012 Jan 17. EMBO J. 2012. PMID: 22252131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources